Business Description
Fisher & Paykel Healthcare Corp Ltd
ISIN : NZFAPE0001S2
Share Class Description:
FRA:FPLB: Ordinary SharesDescription
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the US, 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.77 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | 0.34 | |||||
| Interest Coverage | 19.99 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 27.58 | |||||
| Beneish M-Score | -2.82 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3.7 | |||||
| 3-Year EBITDA Growth Rate | -23.3 | |||||
| 3-Year EPS without NRI Growth Rate | -37 | |||||
| 3-Year FCF Growth Rate | -41.3 | |||||
| 3-Year Book Growth Rate | 4.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 54.32 | |||||
| Future 3-5Y Total Revenue Growth Rate | 12.76 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 68.13 | |||||
| 9-Day RSI | 64.39 | |||||
| 14-Day RSI | 62.05 | |||||
| 6-1 Month Momentum % | 22.64 | |||||
| 12-1 Month Momentum % | 48.85 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.06 | |||||
| Quick Ratio | 1.17 | |||||
| Cash Ratio | 0.31 | |||||
| Days Inventory | 165.85 | |||||
| Days Sales Outstanding | 45.78 | |||||
| Days Payable | 77.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.08 | |||||
| Dividend Payout Ratio | 1.37 | |||||
| 3-Year Dividend Growth Rate | 9.2 | |||||
| Forward Dividend Yield % | 0.94 | |||||
| 5-Year Yield-on-Cost % | 2.17 | |||||
| 3-Year Average Share Buyback Ratio | -0.4 | |||||
| Shareholder Yield % | 1.38 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 60.6 | |||||
| Operating Margin % | 15.26 | |||||
| Net Margin % | 9.46 | |||||
| FCF Margin % | 20.54 | |||||
| ROE % | 9.84 | |||||
| ROA % | 7.53 | |||||
| ROIC % | 8.28 | |||||
| ROC (Joel Greenblatt) % | 18.38 | |||||
| ROCE % | 15.63 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 125.99 | |||||
| Forward PE Ratio | 60.87 | |||||
| PE Ratio without NRI | 125.99 | |||||
| Shiller PE Ratio | 77.94 | |||||
| Price-to-Owner-Earnings | 275.72 | |||||
| PEG Ratio | 1259.9 | |||||
| PS Ratio | 11.9 | |||||
| PB Ratio | 11.55 | |||||
| Price-to-Tangible-Book | 12.11 | |||||
| Price-to-Free-Cash-Flow | 57.91 | |||||
| Price-to-Operating-Cash-Flow | 44.35 | |||||
| EV-to-EBIT | 70.71 | |||||
| EV-to-Forward-EBIT | 30.65 | |||||
| EV-to-EBITDA | 50.4 | |||||
| EV-to-Forward-EBITDA | 24.19 | |||||
| EV-to-Revenue | 11.84 | |||||
| EV-to-Forward-Revenue | 11.19 | |||||
| EV-to-FCF | 57.64 | |||||
| Price-to-Projected-FCF | 6.57 | |||||
| Price-to-Median-PS-Value | 1.51 | |||||
| Price-to-Graham-Number | 8.23 | |||||
| Price-to-Net-Current-Asset-Value | 83.85 | |||||
| Earnings Yield (Greenblatt) % | 1.41 | |||||
| FCF Yield % | 1.74 | |||||
| Forward Rate of Return (Yacktman) % | 0.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Fisher & Paykel Healthcare Corp Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,056.708 | ||
| EPS (TTM) (€) | 0.17 | ||
| Beta | 1.34 | ||
| Volatility % | 18.76 | ||
| 14-Day RSI | 62.05 | ||
| 14-Day ATR (€) | 0.45343 | ||
| 20-Day SMA (€) | 20.375 | ||
| 12-1 Month Momentum % | 48.85 | ||
| 52-Week Range (€) | 12.7 - 21.8 | ||
| Shares Outstanding (Mil) | 586.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Fisher & Paykel Healthcare Corp Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Fisher & Paykel Healthcare Corp Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Fisher & Paykel Healthcare Corp Ltd Frequently Asked Questions
What is Fisher & Paykel Healthcare Corp Ltd(FRA:FPLB)'s stock price today?
The current price of FRA:FPLB is €21.80. The 52 week high of FRA:FPLB is €21.80 and 52 week low is €12.70.
When is next earnings date of Fisher & Paykel Healthcare Corp Ltd(FRA:FPLB)?
The next earnings date of Fisher & Paykel Healthcare Corp Ltd(FRA:FPLB) is 2025-05-29 Est..
Does Fisher & Paykel Healthcare Corp Ltd(FRA:FPLB) pay dividends? If so, how much?
The Dividend Yield %  of Fisher & Paykel Healthcare Corp Ltd(FRA:FPLB) is 1.08% (As of Today), Highest Dividend Payout Ratio of Fisher & Paykel Healthcare Corp Ltd(FRA:FPLB) was 1.81. The lowest was 0.35. And the median was 0.61. The  Forward Dividend Yield % of Fisher & Paykel Healthcare Corp Ltd(FRA:FPLB) is 0.94%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers